Key points are not available for this paper at this time.
study in nude mice bearing U251MG cell xenografts confirmed these results. Our findings indicate that CREB3 functions as a tumor promoter in glioblastoma, and thus could serve as a treatment target in glioblastoma patients.
Hu et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: